Christine L. Kempton

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

Johnny Mahlangu, Johannes Oldenburg, Ido Paz‐Priel et al. · New England Journal of Medicine · 2018 · 708 citations · Full text

Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)

Marilyn J. Manco‐Johnson, Christine L. Kempton, Mark T. Reding et al. · Journal of Thrombosis and Haemostasis · 2013 · 197 citations · Full text

Parallel-group Trial, Severe Hemophilia A, Hematology +4

Malignant Lymphoma of the Bladder: Evidence From 36 Cases That Low-Grade Lymphoma of the MALT-Type is the Most Common Primary Bladder Lymphoma

Christine L. Kempton, Paul J. Kurtin, David J. Inwards et al. · The American Journal of Surgical Pathology · 1997 · 144 citations

Lymphoid Neoplasia, Urological Research, Urology +10

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

Pier Mannuccio Mannucci, Christine L. Kempton, Carolyn M. Millar et al. · Blood · 2013 · 128 citations · Full text

Effect of late prophylaxis in hemophilia on joint status: a randomized trial

Marilyn J. Manco‐Johnson, Björn Lundin, Sharon Funk et al. · Journal of Thrombosis and Haemostasis · 2017 · 126 citations · Full text